APA (7th ed.) Citation

Djodikromo, M. F., Hermens, R. P., Bemt, B. J. v. d., Smit, Y., Govers, T. M., Bekker, C. L., & Blijlevens, N. M. (2023). Patient-guided dose reduction of tyrosine kinase inhibitors in chronic myeloid leukaemia (RODEO study): Study protocol for a prospective, multicentre, single-arm trial. BMC Cancer, 23(1), 1. https://doi.org/10.1186/s12885-023-10697-6

Chicago Style (17th ed.) Citation

Djodikromo, Melissa F., Rosella PMG Hermens, Bart JF van den Bemt, Yolba Smit, Tim M. Govers, Charlotte L. Bekker, and Nicole MA Blijlevens. "Patient-guided Dose Reduction of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukaemia (RODEO Study): Study Protocol for a Prospective, Multicentre, Single-arm Trial." BMC Cancer 23, no. 1 (2023): 1. https://doi.org/10.1186/s12885-023-10697-6.

MLA (9th ed.) Citation

Djodikromo, Melissa F., et al. "Patient-guided Dose Reduction of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukaemia (RODEO Study): Study Protocol for a Prospective, Multicentre, Single-arm Trial." BMC Cancer, vol. 23, no. 1, 2023, p. 1, https://doi.org/10.1186/s12885-023-10697-6.